摘要
目的:探讨11β-羟基类固醇脱氢酶(11β-HSD)与促炎性细胞因子在川崎病(KD)发生、发展中的变化及意义。方法:应用Real-time PCR检测KD患儿急性期及治疗后外周血单核细胞内11β-HSD mRNA的表达,应用免疫印迹方法检测11β-HSD蛋白的表达;应用酶联免疫吸附试验检测血浆IL-17A和IL-6水平。结果:病例组患儿治疗前外周血单核细胞内11β-HSD1 mRNA表达水平及IL-17A和IL-6水平分别为7.13±0.79、(43.40±5.20)pg/m L、(68.30±6.26)pg/m L,较正常对照组1.00±0.07、(24.30±2.26)pg/m L、(30.04±2.86)pg/m L明显升高(P<0.01),而治疗后结果分别为3.43±0.52、(27.30±2.50)pg/m L、(38.30±3.50)pg/m L,均较治疗前明显下降(P<0.01);治疗前11β-HSD2 mRNA表达水平为0.32±0.05,明显低于正常对照组1.00±0.06(P<0.01),治疗后水平为0.82±0.04,较治疗前明显升高(P<0.01)。免疫印迹检测11β-HSD蛋白表达水平的结果分析与11β-HSD mRNA表达水平结果分析一致。结论:KD急性期11β-HSD、促炎性细胞因子在调节KD炎症反应中发挥着重要作用。
Objective: To investigate the changes and significance of 11β-hydroxysteroid dehydrogenase( 11β-HSD) and proinflammatory cytokines in the occurrence and development of Kawasaki disease( KD). Methods: Real-time PCR was performed to detect the mRNA expressions of 11β-HSD in peripheral blood monocytes in acute phase and after treatment. Western blot was performed to detect the protein expressions of 11β-HSD. ELISA was performed to detect the levels of IL-6 and IL-17 in plasma. Results: The expression levels of 11β-HSD1 mRNA,IL-17 A and IL-6 in acute phase were 7.13± 0.79,( 43.40± 5.20) pg / m L,( 68.30± 6.26) pg / m L,significantly higher than the normal levels 1. 00 ± 0. 07,( 24. 30 ± 2. 26) pg / m L,( 30. 04 ± 2. 86) pg / m L( P〈0. 01),after treatment the levels were 3. 43 ± 0. 52,( 27. 30 ± 2. 50) pg / m L,( 38. 30 ± 3. 50) pg / m L,which were significantly reduced than before( P〈0.05). The expression level of 11β-HSD2 mRNA was 0.32± 0.05 before treatment,lower than the normal group( P〈0.01),while significantly increased after treatment than before( P〈0.01). The results of Western blot were consistent with those of Real-time PCR. Conclusion: 11β-HSD and the level of proinflammatory cytokines in acute phase of KD are important factors in regulating inflammatory responses.
出处
《儿科药学杂志》
CAS
2016年第8期1-3,共3页
Journal of Pediatric Pharmacy
基金
西安市卫生局科技项目
编号J2011031